These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 22944694

  • 41. Effect of bauhinia bauhinioides kallikrein inhibitor on endothelial proliferation and intracellular calcium concentration.
    Bilgin M, Burgazli KM, Rafiq A, Mericliler M, Neuhof C, Oliva ML, Parahuleva M, Soydan N, Doerr O, Abdallah Y, Erdogan A.
    Eur Rev Med Pharmacol Sci; 2014; 18(1):46-51. PubMed ID: 24452941
    [Abstract] [Full Text] [Related]

  • 42. Receptors and mechanisms mediating the biphasic response evoked by bradykinin in rat colonic smooth muscle.
    Würner L, Diener M.
    Neurogastroenterol Motil; 2013 Sep; 25(9):e581-90. PubMed ID: 23742018
    [Abstract] [Full Text] [Related]

  • 43. Bifunctional ligands of the bradykinin B2 and B1 receptors: An exercise in peptide hormone plasticity.
    Marceau F, Bawolak MT, Fortin JP, Morissette G, Roy C, Bachelard H, Gera L, Charest-Morin X.
    Peptides; 2018 Jul; 105():37-50. PubMed ID: 29802875
    [Abstract] [Full Text] [Related]

  • 44. Effect of 3-substituted 1,4-benzodiazepin-2-ones on bradykinin-induced smooth muscle contraction.
    Virych PA, Shelyuk OV, Kabanova TA, Khalimova EI, Martynyuk VS, Pavlovsky VI, Andronati SA.
    Ukr Biochem J; 2017 Jul; 89(1):31-7. PubMed ID: 29236387
    [Abstract] [Full Text] [Related]

  • 45. Bauhinia bauhinioides plasma kallikrein inhibitor: interaction with synthetic peptides and fluorogenic peptide substrates related to the reactive site sequence.
    Oliva ML, Mendes CR, Santomauro-Vaz EM, Juliano MA, Mentele R, Auerswald EA, Sampaio MU, Sampaio CA.
    Curr Med Chem; 2001 Jul; 8(8):977-84. PubMed ID: 11375765
    [Abstract] [Full Text] [Related]

  • 46. Kallikrein activates bradykinin B2 receptors in absence of kininogen.
    Biyashev D, Tan F, Chen Z, Zhang K, Deddish PA, Erdös EG, Hecquet C.
    Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1244-50. PubMed ID: 16272198
    [Abstract] [Full Text] [Related]

  • 47. Pharmacological Activities and Hydrolysis by Peptidases of [Phospho-Ser(6)]-Bradykinin (pS(6)-BK).
    Assis DM, Juliano L, Paschoalin T, Kouyoumdjian M, Calixto JB, Santos RA, Pertinhez TA, Gauthier F, Moreau T, Blaber M, Juliano MA.
    Biochem Pharmacol; 2015 Sep 15; 97(2):203-14. PubMed ID: 26235942
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Release of a new vascular permeability enhancing peptide from kininogens by human neutrophil elastase.
    Imamura T, Tanase S, Hayashi I, Potempa J, Kozik A, Travis J.
    Biochem Biophys Res Commun; 2002 Jun 07; 294(2):423-8. PubMed ID: 12051729
    [Abstract] [Full Text] [Related]

  • 50. The kallikrein-kinin system: current and future pharmacological targets.
    Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A.
    J Pharmacol Sci; 2005 Sep 07; 99(1):6-38. PubMed ID: 16177542
    [Abstract] [Full Text] [Related]

  • 51. Bradykinin-related peptides (BRPs) from skin secretions of three genera of phyllomedusine leaf frogs and their comparative pharmacological effects on mammalian smooth muscles.
    Jiang Y, Xi X, Ge L, Yang N, Hou X, Ma J, Ma C, Wu Y, Guo X, Li R, Zhou M, Wang L, Chen T, Shaw C.
    Peptides; 2014 Feb 07; 52():122-33. PubMed ID: 24394432
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Structure of BbKI, a disulfide-free plasma kallikrein inhibitor.
    Zhou D, Hansen D, Shabalin IG, Gustchina A, Vieira DF, de Brito MV, Araújo AP, Oliva ML, Wlodawer A.
    Acta Crystallogr F Struct Biol Commun; 2015 Aug 07; 71(Pt 8):1055-62. PubMed ID: 26249699
    [Abstract] [Full Text] [Related]

  • 54. Effects of a Peptide Derived from the Primary Sequence of a Kallikrein Inhibitor Isolated from Bauhinia bauhinioides (pep-BbKI) in an Asthma-COPD Overlap (ACO) Model.
    Silva LLSD, Barbosa JAS, João JMLG, Fukuzaki S, Camargo LDN, Dos Santos TM, Campos EC, Costa AS, Saraiva-Romanholo BM, Bezerra SKM, Lopes FTQDS, Bonturi CR, Oliva MLV, Leick EA, Righetti RF, Tibério IFLC.
    Int J Mol Sci; 2023 Jul 09; 24(14):. PubMed ID: 37511021
    [Abstract] [Full Text] [Related]

  • 55. Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors.
    Duka A, Kintsurashvili E, Duka I, Ona D, Hopkins TA, Bader M, Gavras I, Gavras H.
    Hypertension; 2008 May 09; 51(5):1352-7. PubMed ID: 18347228
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Further pharmacological evaluation of a novel synthetic peptide bradykinin B2 receptor agonist.
    Savard M, Labonté J, Dubuc C, Neugebauer W, D'Orléans-Juste P, Gobeil F.
    Biol Chem; 2013 Mar 09; 394(3):353-60. PubMed ID: 23362191
    [Abstract] [Full Text] [Related]

  • 59. Binding affinities and activation of Asp712Ala and Cys100Ser mutated kinin B1 receptor forms suggest a bimodal scheme for the molecule of bound-DABK.
    Rodrigues ES, Martin RP, Silva RF, Nakaie CR, Oliveira L, Shimuta SI.
    Regul Pept; 2013 Feb 10; 181():37-44. PubMed ID: 23318500
    [Abstract] [Full Text] [Related]

  • 60. Prolonged signalling and trafficking of the bradykinin B2 receptor stimulated with the amphibian peptide maximakinin: insight into the endosomal inactivation of kinins.
    Bawolak MT, Roy C, Gera L, Marceau F.
    Pharmacol Res; 2012 Feb 10; 65(2):247-53. PubMed ID: 22108573
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.